EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Improved concordance of challenging human epidermal growth factor receptor 2 dual in‐situ hybridisation cases with the use of a digital image analysis algorithm in breast cancer

Madeline Gough iD, Cheng Liu, Bhuvana Srinivasan, Lisa Wilkinson, Louisa Dunk, Yuanhao Yang iD, Veronika Schreiber, Haitham Tuffaha iD, Thomas Kryza iD, John D Hooper iD, Sunil R Lakhani iD, Cameron E Snell iD

Histopathology · 2023

DOI: 10.1111/his.15000 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Histopathology, 2023. Verfasst von Madeline Gough und 11 weiteren Autor:innen. Beteiligte Einrichtung: Mater Pathology, Duncombe Building, Raymond Terrace, South Brisbane, Australia. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: RCPA Quality Assurance Programs Research, Mater Foundation, Roche Diagnostics.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Accurate assessment of human epidermal growth factor receptor 2 (HER2) expression by HER2 immunohistochemistry and in‐situ hybridisation (ISH) is critical for the management of patients with breast cancer. The revised 2018 ASCO/CAP guidelines define 5 groups based on HER2 expression and copy number. Manual pathologist quantification by light microscopy of equivocal and less common HER2 ISH groups (groups 2–4) can be challenging, and there are no data on interobserver variability in reporting of these cases. We sought to determine whether a digital algorithm could improve interobserver variability in the assessment of difficult HER2 ISH cases. Methods and results HER2 ISH was evaluated in a cohort enriched for less common HER2 patterns using standard light microscopy versus analysis of whole slide images using the Roche uPath HER2 dual ISH image analysis algorithm. Standard microscopy demonstrated significant interobserver variability with a Fleiss's kappa value of 0.471 (fair–moderate agreement) improving to 0.666 (moderate–good) with the use of the algorithm. For HER2 group designation (groups 1–5), there was poor–moderate reliability between pathologists by microscopy [intraclass correlation coefficient (ICC) = 0.526], improving to moderate–good agreement (ICC = 0.763) with the use of the algorithm. In subgroup analysis, the algorithm improved concordance particularly in groups 2, 4 and 5. Time to enumerate cases was also significantly reduced.

Conclusion

This work demonstrates the potential of a digital image analysis algorithm to improve the concordance of pathologist HER2 amplification status reporting in less common HER2 groups. This has the potential to improve therapy selection and outcomes for patients with HER2‐low and borderline HER2‐amplified breast cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsHumansFemaleIn Situ Hybridization, FluorescenceReproducibility of ResultsErb-b2 Receptor Tyrosine KinasesAlgorithmsBiomarkers, Tumor

Stichwörter der Autor:innen

ERBB2HER2breast cancerbright-field ISHdigital pathologyimage analysisin-situ hybridisation

Substanzen

Erb-b2 Receptor Tyrosine KinasesBiomarkers, TumorERBB2 protein, human

Autor:innen und Institutionen

  • Mater Pathology, Duncombe Building, Raymond Terrace, South Brisbane, Australia.
  • Mater Research Institute, Translational Research Institute, Woolloongabba, Australia.
  • Faculty of Medicine, The University of Queensland, Herston, Australia.
  • Centre for the Business and Economics of Health, The University of Queensland, St Lucia, Australia.
  • Centre for Clinical Research, The University of Queensland, Herston, Australia.
  • Pathology Queensland, The Royal Brisbane Women's Hospital, Herston, Australia.

ORCID-Profile: Madeline Gough, Yuanhao Yang, Haitham Tuffaha, Thomas Kryza, John D Hooper, Sunil R Lakhani, Cameron E Snell

Förderung

  • RCPA Quality Assurance Programs Research
  • Mater Foundation
  • Roche Diagnostics
  • University of Queensland Graduate School
  • Mater Foundation and Equity Trustees (The KC & BM Thomson Memorial Fund)

Zitieren

APA

Gough, M., Liu, C., Srinivasan, B., Wilkinson, L., Dunk, L., Yang, Y., Schreiber, V., Tuffaha, H., Kryza, T., Hooper, J. D., Lakhani, S. R., & Snell, C. E. (2023). Improved concordance of challenging human epidermal growth factor receptor 2 dual in‐situ hybridisation cases with the use of a digital image analysis algorithm in breast cancer. Histopathology. https://doi.org/10.1111/his.15000

Vancouver

Gough M, Liu C, Srinivasan B, Wilkinson L, Dunk L, Yang Y, et al. Improved concordance of challenging human epidermal growth factor receptor 2 dual in‐situ hybridisation cases with the use of a digital image analysis algorithm in breast cancer. Histopathology. 2023. doi:10.1111/his.15000

BibTeX
@article{Gough2023,
  author = {Gough, Madeline and Liu, Cheng and Srinivasan, Bhuvana and Wilkinson, Lisa and Dunk, Louisa and Yang, Yuanhao and Schreiber, Veronika and Tuffaha, Haitham and Kryza, Thomas and Hooper, John D and Lakhani, Sunil R and Snell, Cameron E},
  title = {Improved concordance of challenging human epidermal growth factor receptor 2 dual in‐situ hybridisation cases with the use of a digital image analysis algorithm in breast cancer},
  journal = {Histopathology},
  year = {2023},
  doi = {10.1111/his.15000}
}
Kostenlos starten →